근거 |
2010 Nov. 24 the Lancet doi:10.1016/S0140-6736(10)61272-X
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G Athyros MDa, Konstantinos Tziomalos MDb, Thomas D Gossios MDc, Theodora Griva MDa, Panagiotis Anagnostis MDd, Konstantinos Kargiotis MDa, Efstathios D Pagourelias MDc, Eleni Theocharidou MDa, Prof Asterios Karagiannis MDa, Dr Dimitri P Mikhailidis FRCPathe, and for the GREACE Study Collaborative Group‡
a Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece
b First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece
c First Cardiology Clinic, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece
d Endocrinology Clinic, Hippokration Hospital, Thessaloniki, Greece
e Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free Campus, University College London Medical School, University College London, London, UK |